BROMOCRIPTINE MESYLATE vs PALSONIFY

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 20, 2026·How we rate

Possible drug interaction. BROMOCRIPTINE MESYLATE and PALSONIFY are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	BROMOCRIPTINE MESYLATE	PALSONIFY
Rating	60/100	New
Pharmacy pays	~$52.02 /30	—
Type	RX	RX
Active ingredient	BROMOCRIPTINE MESYLATE	PALTUSOTINE HYDROCHLORIDE
Manufacturer	Zydus Pharms USA Inc	Crinetics
Dosage forms	Tablet, Capsule	Tablet
Drug class	Ergot Derivative	—
Boxed warning	None	None
Half-life	about 4.85 hours	—
Treats	Acromegaly, Adenoma, Amenorrhea	Acromegaly

bromocriptine mesylate palsonify

Rating

60/100

New

Pharmacy pays

~$52.02 /30

—

Type

Active ingredient

BROMOCRIPTINE MESYLATE

PALTUSOTINE HYDROCHLORIDE

Manufacturer

Zydus Pharms USA Inc

Crinetics

Dosage forms

Tablet, Capsule

Tablet

Drug class

Ergot Derivative

—

Boxed warning

None

Half-life

about 4.85 hours

—

Treats

Acromegaly, Adenoma, Amenorrhea

Acromegaly

Frequently asked questions

What is the difference between Bromocriptine Mesylate and Palsonify?

Bromocriptine Mesylate contains Bromocriptine Mesylate, while Palsonify contains Paltusotine Hydrochloride — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.